You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas

 

Online download statistics by month:

Online download statistics by month: June 2023 to December 2025

AbstractFullPdf
Jun 202315515617
Jul 2023647655242
Aug 202334835198
Sep 202319419557
Oct 202315815849
Nov 202315215250
Dec 202313013272
Jan 202410510864
Feb 2024888842
Mar 202412812880
Apr 202411311387
May 2024848455
Jun 202411711950
Jul 2024979849
Aug 2024868638
Sep 2024707041
Oct 2024909040
Nov 202416416574
Dec 202410911151
Jan 202510110157
Feb 2025848448
Mar 2025868644
Apr 202510610741
May 202510811052
Jun 2025767631
Jul 2025110
Oct 2025112
Dec 2025550
Total360336301531